[Gene therapy of pancreatic cancer with microencapsulated CYP2B1-expressing cells].
Löhr
M
M
II. Medizinische Universitätsklinik, Fakultät für Klinische Medizin Mannheim, Universität Heidelberg, Germany. matthias.loehr@med.mauni-heidelberg.de
Faulmann
G
G
Hummel
F
F
Singer
M V
MV
D000818:Animals; D002460:Cell Line; D002986:Clinical Trials as Topic; D019362:Cytochrome P-450 CYP2B1 / Q000235:genetics*; D004339:Drug Compounding; D015316:Genetic Therapy; D006801:Humans; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D015996:Survival Rate; D013552:Swine; D014162:Transfection
D019362:Cytochrome P-450 CYP2B1
Gentherapie des Pankreaskarzinoms mit mikroverkapselten, CYP2B1-exprimierenden Zellen.